[1] Cheng Q, Zhang H, Shang Y, et al.Clinical features and risk factors analysis of bronchitis obliterans due to refractory Mycoplasma pneumoniae pneumonia in children: a nomogram prediction model[J].BMC Infect Dis, 2021, 21(1):1085. [2] Lee E, Lee YY, Lee E, et al.Predictive factors of the responses to treatment of Mycoplasma pneumoniae pneumonia[J].J Clin Med, 2021, 10(6):1154. [3] 张芳芳, 张小玲, 刘艳.难治性肺炎支原体肺炎患儿T淋巴细胞亚群和高迁移率族蛋白B1的表达水平及临床意义[J].儿科药学杂志, 2020, 26(8):6-9. [4] 吴爱萍, 朱斌.支原体肺炎患儿血清sB7-H3、IFN-γ、GM-CSF的变化观察[J].临床肺科杂志, 2019, 24(6):1042-1045. [5] 郭轲, 张瑜, 陈若才, 等.血小板参数、CRP、LDH联合影像学表现在儿童难治性支原体肺炎诊断和预后中的价值研究[J].湖南师范大学学报(医学版), 2020, 17(5):179-182. [6] 江载芳, 申昆玲, 沈颖.诸福棠实用儿科学[M].第8版.北京: 人民卫生出版社, 2015: 1280-1282. [7] 路瑞静, 王丰, 周坤朋, 等.2017—2019年深圳市宝安区儿童肺炎支原体呼吸道感染的流行病学特征分析[J].实用预防医学, 2020, 27(11):1353-1355. [8] Zhai YY, Wu SZ, Yang Y, et al.An analysis of 20 clinical cases of refractory Mycoplasma pneumoniae pneumonia in children[J].Ann Palliat Med, 2020, 9(5):2592-2599. [9] Ling Y, Zhang T, Guo W, et al.Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children[J].BMC Infect Dis, 2020, 20(1):534. [10] Zhu Z, Zhang T, Guo W, et al.Clinical characteristics of refractory Mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy[J].BMC Infect Dis, 2021, 21(1):126. [11] 管峥, 霍洁, 袁晶, 等.血清乳酸脱氢酶联合白细胞介素18对儿童难治性肺炎支原体肺炎的预测作用[J].实用医学杂志, 2020, 36(20):2848-2851. [12] 郑雪香, 林继雷, 代继宏, 等.基于决策曲线和剂量反应分析评估乳酸脱氢酶对儿童难治性肺炎支原体肺炎的预测价值[J].中国当代儿科杂志, 2020, 22(2):112-117. [13] Tamiya S, Yoshikawa E, Ogura M, et al.Neutrophil-mediated lung injury both via TLR2-dependent production of IL-1alpha and IL-12 p40, and TLR2-independent CARDS toxin after Mycoplasma pneumoniae infection in mice[J].Microbiol Spectr, 2021, 9(3):e0158821. [14] Lofgren D, Lenkeit C.Lofgren D, et al.Mycoplasma pneumoniae-induced rash and mucositis: a systematic review of the literature[J].Spartan Med Res J, 2021, 6(2):25284. [15] Liu Y, Zhang X, Wang Y, et al.The role of granulocyte macrophage colony stimulating factor in hospitalized children with Mycoplasma pneumoniae pneumonia[J].J Infect Chemother, 2018, 24(10):789-794. [16] Gong H, Sun B, Chen Y, et al.The risk factors of children acquiring refractory Mycoplasma pneumoniae pneumonia: a meta-analysis[J].Medicine (Baltimore), 2021, 100(11):e24894.